𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival

✍ Scribed by Michele Orditura; Ciro Romano; Ferdinando De Vita; Gennaro Galizia; Eva Lieto; Stefania Infusino; Giuseppe De Cataldis; Giuseppe Catalano

Publisher
Springer-Verlag
Year
2000
Tongue
English
Weight
113 KB
Volume
49
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Epidermal growth factor receptor mutatio
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
✍ Jin-Yuan Shih; Chien-Hung Gow; Chong-Jen Yu; Chih-Hsin Yang; Yih-Leong Chang; Me πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 161 KB πŸ‘ 2 views

## Abstract Recently, mutations in the __epidermal growth factor receptor__ (__EGFR__) gene in nonsmall cell lung cancer (NSCLC) patients were reported to correlate with gefitinib response. Less than 30% of NSCLC patients are surgically resectable; however, molecular analysis has to rely on nonsurg